AKESOgen, a leader in personalized medicine and genomics, has partnered with Targos and the National Society of Histotechnology to create and assemble an inaugural course on In-situ Hybridization, Microarray & Next-Generation Sequencing in Clinical Diagnostics. The course will be held at the Emory conference center on Oct 26th-28th, 2015. Please click the link below to view the provisional agenda. Additionally, the course will provide CEU credits.
About AKESOgen, Inc.
AKESOgen is an integrated genomics and pharmacogenetics company providing biorepository services and high-throughput, biomarker profiling and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the clinical and R&D market to CLIA standards. A private company based in Atlanta, GA, AKESOgen is a genomics contract research organization that services the academic, pharmaceutical, biotechnology, clinical testing and government sectors. AKESOgen provides expertise in biobanking, assay development and all ancillary services in a purpose-built facility. For more information, visit www.akesogen.com.
About the National Society of Histotechnologists
NSH is the premier source of learning, knowledge and future-oriented research for histology professionals. Attendance provides resources, education, ideas and advocacy to enhance the performance in the laboratory and ultimately the best patient care.